Parmelia perlata (Huds.) Ach. (Charila) is lichen (i.e., symbiotic combination of algae and fungi), a member of the family Parmeliaceae, which is primarily used for its medicinal properties, especially in Asian countries. Present study, was focused to evaluate and validate the pharmacological use of Parmelia perlata as antimicrobial agent against various pathogenic G +ve strains, i.e., Bacillus cereus, Bacillus pumilus, Staphylococcus aureus and Streptococcus pneumoniae G -ve strains, i.e., Pseudomonas aeruginosa, Escherichia coli, Citrobacter freundii and Klebsiella pneumoniae and two species of fungi (Candida albicans and Aspergillus niger). In-vitro, antimicrobial test was performed by disc diffusion method in order to analyze the percentage zone of inhibition. Parmelia perlata showed the good antimicrobial activity against Bacillus cereus respectively. Modified agar well diffusion method was used to measure the minimum inhibitory concentration (MIC) and MIC values lies within the range of 75 to 150 μg /ml for the Gram +ve strains while 75 to 600 μg /ml for G -ve.